Could AI create a brave new world of pharma R&D?Barely a week goes by without one big pharma or biotech announcing that it is using AI to Share XCould AI create a brave new world of pharma R&D?https://deep-dive.pharmaphorum.com/magazine/digital-health/ai-pharma-rd/
How artificial intelligence is empowering healthcareIt is hard to think of any area of our lives that might not one day be affected Share XHow artificial intelligence is empowering healthcarehttps://pharmaphorum.com/views-analysis-digital/how-artificial-intelligence-is-empowering-healthcare/
3rd Annual AI-ML Drug Discovery & Development SummitDiscover Case Studies of Machine Learning in Action Share X3rd Annual AI-ML Drug Discovery & Development Summithttps://pharmaphorum.com/partner-content/3rd-annual-ai-ml-drug-discovery-development-summit-2/
InsightRX pens antibiotic deal for its precision dosing softwareA cloud-based system that makes drug dosing more personalised and precise – developed by InsightRX – is to Share XInsightRX pens antibiotic deal for its precision dosing softwarehttps://pharmaphorum.com/news/insightrx-pens-antibiotic-deal-for-its-precision-dosing-software/
The steps for successful AIWe speak to machine learning expert Loubna Bouarfa about getting life sciences to embrace AI and what makes Share XThe steps for successful AIhttps://pharmaphorum.com/views-analysis-digital/the-steps-for-successful-ai/
Harnessing the potential of AI in commercial life sciencesArtificial intelligence (AI) has gained significant momentum in life sciences over the past few years. With the promise Share XHarnessing the potential of AI in commercial life scienceshttps://deep-dive.pharmaphorum.com/magazine/digital-health/harnessing-the-potential-of-ai-in-commercial-life-sciences/
Bayer chooses UK for its AI-focused R&D hubBayer has continued its policy of setting up R&D hubs to get closer to innovative companies with a Share XBayer chooses UK for its AI-focused R&D hubhttps://pharmaphorum.com/news/bayer-chooses-uk-for-its-artificial-intelligence-focused-rd-hub/
UK AI firm Sensyne makes inroads into US health marketThe UK clinical artificial intelligence (AI) firm Sensyne has announced agreements with a Fortune 200 company, and a Share XUK AI firm Sensyne makes inroads into US health markethttps://pharmaphorum.com/news/uk-ai-firm-sensyne-makes-inroads-into-us-health-market/
Novartis taps Microsoft’s AI expertise for drug developmentNovartis has forged an alliance with Microsoft that will apply artificial intelligence and machine-learning to the discovery, development Share XNovartis taps Microsoft’s AI expertise for drug developmenthttps://pharmaphorum.com/news/novartis-taps-microsofts-ai-expertise-for-drug-development/